Get Clarity, Not Just Headlines.
Published loading...Updated

BNP Paribas Financial Markets Purchases Shares of 716,668 ADC Therapeutics SA (NYSE:ADCT)

Summary by defenseworld.net
BNP Paribas Financial Markets purchased a new stake in ADC Therapeutics SA (NYSE:ADCT – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund purchased 716,668 shares of the company’s stock, valued at approximately $1,426,000. BNP Paribas Financial Markets owned about 0.74% of ADC Therapeutics as of its most recent filing with the SEC. Other institutional investors and hedge funds also recently bought…

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Monday, May 19, 2025.
Sources are mostly out of (0)